S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Revenue Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Revenue
â‚©272.9B
CAGR 3-Years
26%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Revenue
â‚©4.2T
CAGR 3-Years
47%
CAGR 5-Years
54%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Revenue
â‚©14.9B
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Revenue
â‚©76.2B
CAGR 3-Years
22%
CAGR 5-Years
21%
CAGR 10-Years
52%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Revenue
â‚©22.7B
CAGR 3-Years
268%
CAGR 5-Years
56%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Revenue
â‚©10.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Revenue?
Revenue
272.9B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Revenue amounts to 272.9B KRW.

What is ST Pharm Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%

Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for ST Pharm Co Ltd have been 26% over the past three years , 32% over the past five years .

Back to Top